Pharmaceutical Industry Information Portal

HomeNews

News

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...

FDA Authorizes Use of Oral Antiviral Molnupiravir for Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has...

Russian Ministry of Health registered Mir-19 anti-coronavirus drug

The Russian Ministry of Health registered the Mir-19 coronavirus pharmaceuticals developed by the Russian Federal Medical-Biological Agency (FMBA), the agency’s press service said. The press...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...

Biokhimik JSC of Promomed Group and Mordovia State University agreed on further cooperation

At the meeting of the management of Biokhimik JSC with Acting Rector of the Ogarev Mordovia State University Dmitry Glushko and the scientific community...

Xevudy (sotrovimab) granted marketing authorisation by the EC for the early treatment of COVID-19

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Commission (EC) has granted marketing authorisation to Xevudy (sotrovimab) for the early treatment of COVID-19....
spot_img

Expert Articles

spot_img